CA9 and colorectal cancer: Immunohistochemical studies in patient biopsies of colorectal cancer have shown that the hypoxia marker CAIX is strongly expressed in “immune cold” tumors (47), which are marked by low or absence of T cell infiltrates and dendritic cells (DC) (48–50).